Insilico Medicine to present on Deep Learning Pipelines for Drug Discovery at GTC DC

IMAGE: Insilico Medicine logo. view more Credit: Insilico Medicine Wednesday, 26th of October, Washington DC – Insilico Medicine, Inc. announced that it will present its most recent advances in applying the deep learning techniques to biomarker development and drug discovery at the GPU Technology Conference Washington DC (GTC DC). Dr. Qingsong Zhu, Chief Operating Officer at Insilico Medicine, will give a presentation on October 27th in the “Heathcare” track. The presentation titled “Deep Learning Pipelines for Drug Discovery” will cover Insilico Medicine’s most recent progress of the applications of deep learning techniques on large transcriptional response data and creating multi-modal biomarkers and predictors of therapeutic use of the drugs for high throughput screening. Deep learning is rapidly advancing in many areas of science and technology, such as imaging, texting, voice recognition,…


Link to Full Article: Insilico Medicine to present on Deep Learning Pipelines for Drug Discovery at GTC DC

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!